Cite
Efficacy and safety of the combination of paclitaxel, cisplatin and bevacizumab for the treatment of non-small cell lung cancer.
MLA
Hui Zhang, et al. “Efficacy and Safety of the Combination of Paclitaxel, Cisplatin and Bevacizumab for the Treatment of Non-Small Cell Lung Cancer.” Tropical Journal of Pharmaceutical Research, vol. 23, no. 4, Apr. 2024, pp. 769–75. EBSCOhost, https://doi.org/10.4314/tjpr.v23i4.13.
APA
Hui Zhang, Lei Fu, Jingwen Jiang, Fangfang Fu, Aiying Chen, Hui Gong, & Fengting Zhu. (2024). Efficacy and safety of the combination of paclitaxel, cisplatin and bevacizumab for the treatment of non-small cell lung cancer. Tropical Journal of Pharmaceutical Research, 23(4), 769–775. https://doi.org/10.4314/tjpr.v23i4.13
Chicago
Hui Zhang, Lei Fu, Jingwen Jiang, Fangfang Fu, Aiying Chen, Hui Gong, and Fengting Zhu. 2024. “Efficacy and Safety of the Combination of Paclitaxel, Cisplatin and Bevacizumab for the Treatment of Non-Small Cell Lung Cancer.” Tropical Journal of Pharmaceutical Research 23 (4): 769–75. doi:10.4314/tjpr.v23i4.13.